Proximal Ventures raises 27 point 5 million dollar debut fund for life sciences AI
First-time manager Sahir Raoof has secured 27.5 million dollars for Proximal Ventures to back early-stage startups applying artificial intelligence to drug development.
FTMQ Startups, written by our newsroom1 view

Proximal Ventures has launched its debut fund with 27.5 million dollars in capital to invest in life sciences startups. TechCrunch Venture, Unite.AI, Dealroom, TradingView, and Business Wire all reported on the closing of the new fund on November 10, 2026. The fund was founded by Sahir Raoof, a former SignalFire investor and healthcare startup executive. [1][2][3][4][5][6]
According to TechCrunch Venture, Proximal Ventures is targeting artificial intelligence applications across the pharmaceutical development lifecycle. TechCrunch Venture reported that the firm is focusing on tools, infrastructure, and services that support drug development. This includes services ranging from synthesizing molecular compounds to manufacturing drugs and analyzing clinical trials. [1]
Business Wire reported that the firm aims to back AI-native companies reshaping the life sciences sector. TechCrunch Venture noted that first-time fund managers are currently navigating a difficult fundraising market, even as established venture capital firms continue to attract capital. [1][6]
In short
- Proximal Ventures closed its debut fund at 27.5 million dollars.
- The firm was founded by former SignalFire investor Sahir Raoof.
- The fund will invest in startups applying artificial intelligence to drug development and life sciences.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Proximal Ventures raises debut fund to back startups bringing AI to drug developmentTechCrunch Venture, 7d ago (the report this story comes from)
- [2]Proximal Ventures raises debut fund to back startups bringing AI to drug developmentTechCrunch, 7d ago
- [3]Proximal Ventures Closes $27.5M Debut Fund to Back AI Life SciencesUnite.AI, 7d ago
- [4]Proximal Ventures closes $27.5M debut fund for AI in pharmaDealroom, 7d ago
- [5]Proximal Ventures Announces $27.5 Million Debut FundTradingView, 7d ago
- [6]Proximal Ventures Announces $27.5 Million Debut Fund to Invest in AI-Native Companies Reshaping Life SciencesBusiness Wire, 7d ago
Background
- [7]ChatGPT on Wikipedia
- [8]Sony revives 1979 Walkman headphones with modern USB C connectivity FTMQ Startups, 12d ago
- [9]LAUNCHub Ventures Secures 65 Million Euro First Close for Third Fund FTMQ Startups, 37d ago
Our newsroom writes these reports with the help of software, from the 9 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Startups
Earlier reports of ours on the same people and subjects.
- Monte Carlo Capital reaches 15 million dollar first close for Fund IIFunding Rounds, 39d ago
- LAUNCHub Ventures Secures 65 Million Euro First Close for Third FundEcosystems, 37d ago
- Genesys Capital Completes Second Close of Canadian Life Sciences Seed FundFunding Rounds, 33d ago
- Dren Bio secures 350 million dollars for lead cancer drug launchFunding Rounds, 18d ago
- Endeavor Catalyst closes fifth fund with 320 million dollarsTop Stories, 41d ago
More in Funding Rounds
- Protegey secures pre seed funding to expand African risk infrastructure5h ago
- Serena Williams and Beth Ferreira launch Starfire Ventures targeting 200 million dollars1d ago
- Irish venture funding drops to 10 year third quarter low2d ago
- Vision Makers raises four million dollars in seed funding round3d ago
- Mirendil raises 1 billion dollars in Series A funding4d ago
- Web Summit Cancels Second Day in Lisbon Following Severe Storm Warnings5d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.